Medtronic Financial Statements
Medtronic Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | May |
© 2009 Morningstar, Inc. Financial Data provided by
Medtronic Income Statement
| 2009# | 2008 | 2007 | |
|---|---|---|---|
| Revenue ($ mil.) | 14,599.0 | 13,515.0 | 12,299.0 |
| Gross Profit ($ mil.) | 11,081.0 | 10,069.0 | 9,131.0 |
| Operating Income ($ mil.) | 2,811.0 | 3,140.0 | 3,743.0 |
| Total Net Income ($ mil.) | 2,169.0 | 2,231.0 | 2,802.0 |
| Diluted EPS (Net Income) | 1.93 | 1.95 | 2.41 |
- # Fiscal year-end changed since last report from April to May
Medtronic Quarterly Statements
| Quarter Ending Jul 09 | Quarter Ending Apr 09 | Quarter Ending Jan 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,933.0 | 3,829.0 | 3,494.0 |
| Gross Profit ($ mil.) | 2,967.0 | 2,897.0 | 2,646.0 |
| Operating Income ($ mil.) | 627.0 | 100.0 | 984.0 |
| Total Net Income ($ mil.) | 445.0 | 128.0 | 723.0 |
| Diluted EPS (Net Income) | 0.40 | 0.12 | 0.65 |
Medtronic Stock Quote & Chart
11/06/09 16:00:27 EST •
NYSE •
37.97
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Medtronic Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.90 | 2.58 | 7.00 |
| Price/Earnings Ratio | 22.73 | 67.57 | 25.45 |
| Price/Book Ratio | 3.24 | 2.97 | 6.74 |
| Price/Cash Flow Ratio | 11.63 | 14.18 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Medtronic Financial Ratios
Medtronic Competitive Intelligence
| Boston Scientific | Johnson & Johnson | St. Jude Medical | |
|---|---|---|---|
| Annual Sales ($ mil.) | 8,050.0 | 63,747.0 | 4,363.3 |
| Employees | 24,800 | 118,700 | 14,000 |
| Market Cap ($ mil.) | 12,135.4 | 165,490.8 | 12,109.7 |
Competitive Landscape
